Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial
Purpose: To determine whether epoetin alfa reduces anemia-related fatigue, improves other aspects of health-related patient-recorded outcomes (PROs), reduces the number of RBC transfusions, and has an impact on freedom from treatment failure (FFTF) and overall survival (OS) in patients with advanced...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 5, 2010
|
| In: |
Journal of clinical oncology
Year: 2010, Jahrgang: 28, Heft: 13, Pages: 2239-2245 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2009.25.1835 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2009.25.1835 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2009.25.1835 
|
| Verfasserangaben: | Andreas Engert, Andreas Josting, Heinz Haverkamp, Matthias Villalobos, Andreas Lohri, Martin Sökler, Josée Zijlstra, Isrid Sturm, Max S. Topp, Andreas Rank, Thorsten Zenz, Martin Vogelhuber, Lucia Nogova, Peter Borchmann, Michael Fuchs, Hans-Henning Flechtner, and Volker Diehl |